Based on VWAP how will IMAB perform in the MARKET over the next 2 days?

**Conclusion (quick take)**
IMAB just printed a “climax”-volume day yet actually **closed a hair _below_ its intraday VWAP (~$ 2.25 vs close $ 2.23)**.
With an **RSI-14 of 90.7 (extreme over-bought)**, price still 31 % above its 5-day mean, and the close slipping under VWAP, history says the next 48 hours skew toward an early fade into the $ 2.00 – $ 2.15 band before any fresh attempt to re-challenge Thursday’s high ($ 2.68). Expect a noisy $ 1.90 – $ 2.45 box, with downside tests slightly more likely than a straight-up continuation squeeze.

---

### Key VWAP & momentum metrics

| Metric (6 Jun reference) | Value | Signal | Comment |
|---|---|---|---|
| Close vs 1-day VWAP | $ 2.23 vs ≈ $ 2.25 (-0.9 %) | Slightly **below** fair value | Sub-VWAP close after a +25 % session hints at profit-taking pressure |
| Close vs 5-day mean price | $ 2.23 vs $ 1.70 (+31 %) | Stretched | Not yet parabolic like MODV/BW, but rich |
| 1-day volume | 3.24 M sh | ≈7 × 30-day avg (0.46 M) | “Volume climax” often precedes digestion |
| RSI-14 | 90.7 | Extremely over-bought | Pull-backs usually start >80 |
| MACD histogram | +0.24 | Momentum still positive | Dip-buyers lurking |
| ATR-14 | $ 0.23 | ≈10 % daily “routine” swing | Sizes risk |

*VWAP approximation = (High $ 2.68 + Low $ 1.83 + Close $ 2.23) ÷ 3 ≈ $ 2.25.*

---

### 48-hour scenario map

| Scenario | Prob. | Tape tells | Likely path | Target zone |
|----------|-------|------------|-------------|-------------|
| 1. **Post-climax fade** | 45 % | Stays sub-VWAP ≥30 min | Slides to $ 2.02 (VWAP–ATR) → $ 1.90 gap-fill | Buy/cover in $ 1.90–$ 2.05 |
| 2. **VWAP test & hold** | 35 % | Quick flush bought, reclaims VWAP | Chops $ 2.14–$ 2.40 | Scalp both sides of range |
| 3. **Fresh squeeze** | 20 % | Volume >4 M, holds >$ 2.30 | Pops $ 2.48 (VWAP+ATR) → $ 2.70 (VWAP+2 ATR) | Fade $ 2.55–$ 2.70 unless VWAP rises with price |

---

### Translating levels into a trade plan

| Trade idea | Entry trigger | Initial stop | First target | Stretch target | R : R |
|------------|---------------|--------------|--------------|----------------|-------|
| **Long the dip** | Flush into $ 2.00 ± 0.05 → 5-min close back **above** VWAP | $ 1.88 | $ 2.25 | $ 2.38–$ 2.45 | ~1 : 3 |
| **Fade the pop** | Spike to $ 2.55–$ 2.70 that **fails** to hold VWAP on way down | $ 2.82 | $ 2.30 | $ 2.05 | ~1 : 2.5 |

Execution checklist
1. Keep real-time VWAP on 1- & 5-min charts; bias flips with sustained closes above/below it.
2. ATR = $ 0.23 ⇒ a full ATR adverse move ≈ 10 %; size trades so that risk ≤ 1 % of account equity.
3. Scale out quickly—small-cap biotechs often retrace an entire move in one candle.
4. Respect binary risk (China ADR + clinical headlines); overnight holds add gap risk far larger than ATR.

---

### Bottom line
The chart argues for **buying controlled flushes into $ 2.00 – $ 2.10 and/or fading exhaustion pushes above $ 2.55**, always tethered to VWAP. Volatility is high but not yet parabolic; trade the levels, keep stops tight, and let VWAP be your referee over the next two sessions. Good luck!